UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

Journal of clinical oncology, 2001-08, Vol.19 (16), p.3635-3648

2001

Volltextzugriff (PDF)

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

Journal of clinical oncology, 2001-08, Vol.19 (16), p.3622-3634

2001

Volltextzugriff (PDF)

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2253-2260

1998

Volltextzugriff (PDF)

Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients

Journal of clinical oncology, 1999-03, Vol.17 (3), p.976-983

1999

Volltextzugriff (PDF)

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

Annals of oncology, 2017-04, Vol.28 (4), p.868-873

2017

Volltextzugriff (PDF)

A new American Joint Committee on Cancer staging system for cutaneous melanoma

Cancer, 2000-03, Vol.88 (6), p.1484-1491

2000

Volltextzugriff (PDF)

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1039-1051

1997

Volltextzugriff (PDF)

Sentinel Lymph Node Biopsy for Melanoma: Controversy Despite Widespread Agreement

Journal of clinical oncology, 2001-06, Vol.19 (11), p.2851-2855

2001

Volltextzugriff (PDF)

Prognostic factors for survival of patients treated systemically for disseminated melanoma

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1103-1111

1998

Volltextzugriff (PDF)

Burnout and Career Satisfaction Among Surgical Oncologists Compared with Other Surgical Specialties

Annals of surgical oncology, 2011, Vol.18 (1), p.16-25

2011

Volltextzugriff (PDF)

Uncertainties in the management of melanoma nodal metastasis

European journal of surgical oncology, 2015-07, Vol.41 (7), p.811-813

2015

Volltextzugriff (PDF)

Recent advances in the care of the patient with malignant melanoma

Annals of surgery, 1997, Vol.225 (1), p.1-14

1997

Volltextzugriff (PDF)

An Evidence-based Staging System for Cutaneous Melanoma

CA: a cancer journal for clinicians, 2004-05, Vol.54 (3), p.131-149

2004

Volltextzugriff (PDF)

The role of elective lymph node dissection in melanoma: rationale, results, and controversies

Journal of clinical oncology, 1988-01, Vol.6 (1), p.163-172

Balch, C M

1988

Volltextzugriff (PDF)

Factors affecting survival following local, regional, or distant recurrence from localized melanoma

Journal of surgical oncology, 1998-04, Vol.67 (4), p.228-233

1998

Volltextzugriff (PDF)

Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1-4 mm Melanomas

Annals of surgical oncology, 2001-03, Vol.8 (2), p.101-108

Balch, C. M.

2001

Volltextzugriff (PDF)

A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1)

The Journal of immunology (1950), 1981-09, Vol.127 (3), p.1024-1029

1981

Volltextzugriff (PDF)

Prognostic value of size of lymph node metastases in patients with cutaneous melanoma

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2361-2368

1995

Volltextzugriff (PDF)

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger

Annals of surgery, 1996-09, Vol.224 (3), p.255-266

1996

Volltextzugriff (PDF)

A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanoma

Cancer, 1995-01, Vol.75 (1), p.34-42

1995

Volltextzugriff (PDF)

Surgical management and prognostic factors in patients with subungual melanoma

Annals of surgery, 1994-02, Vol.219 (2), p.197-204

1994

Volltextzugriff (PDF)

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

The Journal of immunology (1950), 1985-02, Vol.134 (2), p.802-807

1985

Volltextzugriff (PDF)

Palliative surgery for stage IV melanoma: is it a primary treatment?

Annals of surgical oncology, 1999-10, Vol.6 (7), p.623-624

Balch, C M

1999

Volltextzugriff (PDF)

Characterization of autologous tumor‐specific T‐helper 2 cells in tumor‐infiltrating lymphocytes from a patient with metastatic melanoma

International journal of cancer, 1994-08, Vol.58 (3), p.317-323

1994

Volltextzugriff (PDF)

The importance of lymphatic anatomy in melanoma : A resurgence of clinical significance in an era of sentinel lymph node technology

Journal of the American College of Surgeons, 1999-08, Vol.189 (2), p.204-206

1999

Volltextzugriff (PDF)

1 – 25 von 925

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(760)
Mit Volltextzugriff
(756)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(908)
Japanisch
(134)
Deutsch
(11)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(409)
Journals@Ovid Ovid Full Text
(309)
EZB Electronic Journals Library
(298)
Ingenta
(295)
Publisher website
(211)
Wiley-Blackwell Journals
(147)
Elsevier ScienceDirect Journals Complete
(142)
IngentaConnect Journals
(120)
Wiley Online Library
(116)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(84)
SpringerLink
(80)
Ebook Central Perpetual and DDA
(75)
eBooks on EBSCOhost
(75)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(71)
Jstor Complete Legacy
(36)
Nature
(21)
Oxford Journals Online Current
(19)
SpringerLink Series
(18)
Oxford Journals 2020 Medicine
(11)
Nexis Uni
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

A new American Joint Committee on Cancer staging system for cutaneous melanoma

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

Sentinel Lymph Node Biopsy for Melanoma: Controversy Despite Widespread Agreement

Prognostic factors for survival of patients treated systemically for disseminated melanoma

Burnout and Career Satisfaction Among Surgical Oncologists Compared with Other Surgical Specialties

Uncertainties in the management of melanoma nodal metastasis

Recent advances in the care of the patient with malignant melanoma

An Evidence-based Staging System for Cutaneous Melanoma

The role of elective lymph node dissection in melanoma: rationale, results, and controversies

Factors affecting survival following local, regional, or distant recurrence from localized melanoma

Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1-4 mm Melanomas

A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1)

Prognostic value of size of lymph node metastases in patients with cutaneous melanoma

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger

A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanoma

Surgical management and prognostic factors in patients with subungual melanoma

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

Palliative surgery for stage IV melanoma: is it a primary treatment?

Characterization of autologous tumor‐specific T‐helper 2 cells in tumor‐infiltrating lymphocytes from a patient with metastatic melanoma

The importance of lymphatic anatomy in melanoma : A resurgence of clinical significance in an era of sentinel lymph node technology

Suchergebnisse filtern